LON:SALV

SalvaRx Group (SALV) Share Price, News & Analysis

Today's Range
N/A
50-Day Range
4.50
4.50
52-Week Range
N/A
Volume
50,758 shs
Average Volume
50,758 shs
Market Capitalization
£1.65 million
P/E Ratio
0.03
Dividend Yield
N/A
Price Target
N/A
Receive SALV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SalvaRx Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£64.50 million
Cash Flow
GBX 1.29 per share
Book Value
GBX 15.40 per share

Miscellaneous

Free Float
N/A
Market Cap
£1.65 million
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

SALV Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of SalvaRx Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SalvaRx Group investors own include Premier African Minerals (PREM), Cradle Arc (CRA), Cora Gold (CORA), Big Sofa Technologies Group (BST), Bahamas Petroleum (BPC), Bacanora Lithium (BCN), AutoZone (AZO), Angus Energy (ANGS), Allergy Therapeutics (AGY) and AFR.L (AFR).

How do I buy shares of SalvaRx Group?

Shares of SALV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SALV) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners